275 related articles for article (PubMed ID: 19745037)
1. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
[TBL] [Abstract][Full Text] [Related]
2. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
[TBL] [Abstract][Full Text] [Related]
3. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH
Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
[TBL] [Abstract][Full Text] [Related]
5. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
[TBL] [Abstract][Full Text] [Related]
6. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
[TBL] [Abstract][Full Text] [Related]
9. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
[TBL] [Abstract][Full Text] [Related]
10. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.
Annuzzi G; Piscitelli F; Di Marino L; Patti L; Giacco R; Costabile G; Bozzetto L; Riccardi G; Verde R; Petrosino S; Rivellese AA; Di Marzo V
Lipids Health Dis; 2010 Apr; 9():43. PubMed ID: 20426869
[TBL] [Abstract][Full Text] [Related]
11. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin levels in overweight and obese Asians.
Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
Obes Res; 2002 Nov; 10(11):1104-10. PubMed ID: 12429873
[TBL] [Abstract][Full Text] [Related]
13. High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets.
Woolcott OO; Richey JM; Kabir M; Chow RH; Iyer MS; Kirkman EL; Stefanovski D; Lottati M; Kim SP; Harrison LN; Ionut V; Zheng D; Hsu IR; Catalano KJ; Chiu JD; Bradshaw H; Wu Q; Kolka CM; Bergman RN
PLoS One; 2015; 10(4):e0123558. PubMed ID: 25855974
[TBL] [Abstract][Full Text] [Related]
14. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
Blüher M; Engeli S; Klöting N; Berndt J; Fasshauer M; Bátkai S; Pacher P; Schön MR; Jordan J; Stumvoll M
Diabetes; 2006 Nov; 55(11):3053-60. PubMed ID: 17065342
[TBL] [Abstract][Full Text] [Related]
16. Identification of endocannabinoids and related compounds in human fat cells.
Gonthier MP; Hoareau L; Festy F; Matias I; Valenti M; Bès-Houtmann S; Rouch C; Robert-Da Silva C; Chesne S; Lefebvre d'Hellencourt C; Césari M; Di Marzo V; Roche R
Obesity (Silver Spring); 2007 Apr; 15(4):837-45. PubMed ID: 17426318
[TBL] [Abstract][Full Text] [Related]
17. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
19. Circulating anandamide and blood pressure in patients with obstructive sleep apnea.
Engeli S; Blüher M; Jumpertz R; Wiesner T; Wirtz H; Bosse-Henck A; Stumvoll M; Batkai S; Pacher P; Harvey-White J; Kunos G; Jordan J
J Hypertens; 2012 Dec; 30(12):2345-51. PubMed ID: 23032139
[TBL] [Abstract][Full Text] [Related]
20. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
